SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-035173
Filing Date
2018-06-21
Accepted
2018-06-21 16:36:17
Documents
5
Period of Report
2018-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv496929_8k.htm 8-K 27161
2 EXHIBIT 1.1 tv496929_ex1-1.htm EX-1.1 159618
3 EXHIBIT 4.1 tv496929_ex4-1.htm EX-4.1 100656
4 EXHIBIT 5.1 tv496929_ex5-1.htm EX-5.1 7745
5 EXHIBIT 10.1 tv496929_ex10-1.htm EX-10.1 225923
  Complete submission text file 0001144204-18-035173.txt   522289
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 18912158
SIC: 2834 Pharmaceutical Preparations